These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38394550)

  • 41. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
    Esquenazi A; Albanese A; Chancellor MB; Elovic E; Segal KR; Simpson DM; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():115-28. PubMed ID: 23220492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.
    Chancellor MB; Elovic E; Esquenazi A; Naumann M; Segal KR; Schiavo G; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():129-40. PubMed ID: 23415704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady A; Bennett C; Newton JN; Thomas K; Popescu CM
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002086. PubMed ID: 22895927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum Toxin A for Hair Loss Treatment: A Systematic Review of Efficacy, Safety, and Future Directions.
    Hussein RS; Dayel SB; Abahussein O
    JPRAS Open; 2023 Dec; 38():296-304. PubMed ID: 38021319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
    Marsili L; Bologna M; Jankovic J; Colosimo C
    Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
    [No Abstract]   [Full Text] [Related]  

  • 47. Acne vulgaris and the most popular and new cosmetological treatments.
    Chilicka K; Gold MH; Nowicka D
    J Cosmet Dermatol; 2023 Jul; 22(7):1946-1950. PubMed ID: 37062752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
    Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
    J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Oral Retinoids in Treatment of Acne Vulgaris With a Bioinformatics-Based Perspective of Personalized Medicine.
    Scott-Emuakpor R; Vuthaluru K; Nagre A; Jawed I; Patel PA; Sidhu HK
    Cureus; 2023 Apr; 15(4):e38019. PubMed ID: 37228537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical differences between botulinum neurotoxin type A and B.
    Bentivoglio AR; Del Grande A; Petracca M; Ialongo T; Ricciardi L
    Toxicon; 2015 Dec; 107(Pt A):77-84. PubMed ID: 26260691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the role of botulinum toxin in critical care.
    Hafeez MU; Moore M; Hafeez K; Jankovic J
    Expert Rev Neurother; 2021 Aug; 21(8):881-894. PubMed ID: 34281468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
    Blumenfeld AM; Dodick DW; Silberstein SD
    Dermatol Clin; 2004 Apr; 22(2):167-75. PubMed ID: 15222577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Herbal Medicine in the Treatment of Acne Vulgaris: A Systematic Review of Clinical Trials.
    Proença AC; Luís Â; Duarte AP
    Evid Based Complement Alternat Med; 2022; 2022():2011945. PubMed ID: 35754694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum Neurotoxin and Its Potential Role in the Treatment of Erectile Dysfunction.
    Ghanem H; Raheem AA; AbdelRahman IFS; Johnson M; Abdel-Raheem T
    Sex Med Rev; 2018 Jan; 6(1):135-142. PubMed ID: 28843941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
    Luvisetto S; Gazerani P; Cianchetti C; Pavone F
    Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The microsponge delivery system reduces facial oiliness and shine during acne therapy.
    Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11):1268-70. PubMed ID: 24196335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of topical spironolactone in the treatment of acne: A systematic review of clinical trials-Does this therapy open a path towards favorable outcomes?
    Rehan ST; Khan Z; Abbas S; Imran L; Munir S; Tahir MJ; Kheljee AZ; Eljack MMF; Ahmed A
    J Dermatol; 2023 Feb; 50(2):166-174. PubMed ID: 36412248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical evaluation of the efficacy of a facial serum containing dioic acid, glycolic acid, salicylic acid, LHA, citric acid, and HEPES in treating post-inflammatory hyperchromia and controlling oily skin in patients with acne vulgaris.
    Campos V; Pitassi L; Kalil C; Gonçalves Júnior JE; Sant'Anna B; Correia P
    J Cosmet Dermatol; 2021 Jun; 20(6):1766-1773. PubMed ID: 33617668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin injections for low-back pain and sciatica.
    Waseem Z; Boulias C; Gordon A; Ismail F; Sheean G; Furlan AD
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008257. PubMed ID: 21249702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.